Scott Best Selected Research

obinutuzumab

1/2021

Entospletinib and obinutuzumab in patients with relapsed/refractory chronic lymphocytic leukemia and B-cell malignancies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Scott Best Research Topics

Disease

6	Neoplasms (Cancer) 01/2023 - 01/2019
4	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2023 - 12/2019
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2021 - 01/2019
2	Lymphoma (Lymphomas) 09/2021 - 12/2019
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2019 - 01/2019
1	Hematologic Neoplasms (Hematological Malignancy) 01/2023
1	Leukemia 09/2021
1	T-Cell Lymphoma (Lymphoma, T Cell) 09/2021
1	Multiple Myeloma 12/2019
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 12/2019
1	Carcinogenesis 01/2019
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2019

Drug/Important Bio-Agent (IBA)

3	pevonedistatIBA 10/2021 - 01/2021
3	EnzymesIBA 10/2021 - 01/2021
2	Antigen-Antibody Complex (Immune Complex)IBA 01/2023 - 01/2021
2	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 01/2023 - 01/2021
2	UbiquitinIBA 12/2019 - 01/2019
2	Ubiquitin-Activating Enzymes (Ubiquitin-Activating Enzyme)IBA 12/2019 - 01/2019
2	Proteasome InhibitorsIBA 12/2019 - 01/2019
2	TAK-243IBA 12/2019 - 01/2019
1	6- (1H- indazol- 6- yl)- N- (4- morpholinophenyl)imidazo(1,2- a)pyrazin- 8- amineIBA 01/2021
1	obinutuzumabIBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	Bortezomib (Velcade)FDA Link 12/2019
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 12/2019
1	Proteasome Endopeptidase Complex (Proteasome)IBA 12/2019
1	ibrutinibIBA 12/2019
1	Lenalidomide (CC 5013)FDA Link 12/2019
1	DNA-Directed RNA Polymerases (RNA Polymerase)IBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	CyclinsIBA 01/2019

Therapy/Procedure

2	Therapeutics 01/2023 - 01/2021
1	Immunotherapy 01/2023